HESI eSTAR Annual Meeting Objectives
HESI eSTAR: Progress in (metabol)omics-based chemical grouping
HESI eSTAR: microRNA Biomarker
HESI eSTAR: TgX DDI Biomarker Qualification
HESI eSTAR: Transcriptomic POD
HESI eSTAR: Carcinogenomics Project
Understanding Cell Biology and Toxicology with Spatial Transcriptomics: use Cases and Bioinformatic Platforms
Phenotypically Anchored mRNA & miRNA Expression Profiling in Zebrafish Reveals Flame Retardant Chemical Toxicity Networks
Tox-GAN: An AI Approach Alternative to Animal Studies – a Case Study with Toxicogenomics
Feb 17, 2022
Interplay between chemical and biological spaces: opportunities for toxicity prediction and compound de novo design
June 7, 2021
Transcriptomics read across for mechanism of action characterization
April 19, 2021
FASTBMD: an Online Tool for Rapid Benchmark Dose-Response Analysis of Transcriptomics Data
March 9, 2021
Transcriptomic Point of Departure (tPOD): Review of Chemical Domains, Experimental Design and Comparison to Long-term Apical Effect Concentrations
December 10, 2020
Elaborating & Quantifying the DARTable genome for prediction of Teratogenic Doses.
August 4, 2020
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-3859
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.